ClearPoint Neuro (CLPT) Stock Statistics & Valuation Metrics

ClearPoint Neuro has a market cap or net worth of $548.08M. The enterprise value is $331.32M.

ClearPoint Neuro has 28,427,418 shares outstanding. The number of shares has decreased by -2.65% in one year.

ClearPoint Neuro’s return on equity (ROE) is -0.74 and return on invested capital (ROIC) is -67.18%.

The current PE Ratio of ClearPoint Neuro is ―. ClearPoint Neuro’s PEG ratio is 0.99.

In the last 12 months, ClearPoint Neuro had revenue of 31.39M and earned -18.91M in profits. Earnings per share was -0.70.

In the last 12 months, operating cash flow was -11.17M and capital expenditures -549.00K, giving a free cash flow of -11.71M billion.

ClearPoint Neuro pays an annual dividend of ―, resulting in a dividend yield of ―

ClearPoint Neuro upcoming earnings date is Nov 11, 2025, After Close (Confirmed).

ClearPoint Neuro as a current ratio of 3.22, with Debt / Equity ratio of 33.49%

In the past 12 months, ClearPoint Neuro has paid 0.00 in taxes.

ClearPoint Neuro EV to EBITDA ratio is -22.37, with an EV/FCF ratio of -43.27.

ClearPoint Neuro has $41.54M in cash and marketable securities with $6.61M in debt, giving a net cash position of $34.93M billion.

Gross margin is 60.42%, with operating margin of -62.91%, and net profit margin of -60.25%.

The average price target for ClearPoint Neuro is $25.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy